In this escape mechanism, the KLRG1–CD2 axis is important, and targeting N-cadherin seems to be an effective strategy to prevent circulating tumor cells from homing onto the primary tumor and resisting NKC-mediated lysis. The gene discussed is CD2; the disease is neoplasm.